Hosier, G. W., and N. J. Touma. “Response of Renal Cell Carcinoma to Ibrutinib, a Bruton Tyrosine Kinase Inhibitor, in a Patient Treated for Chronic Lymphocytic Leukemia”. Canadian Urological Association Journal, vol. 11, no. 5, May 2017, pp. E237-9, doi:10.5489/cuaj.4316.